Richard Close
Stock Analyst at Canaccord Genuity
(1.22)
# 3,653
Out of 5,176 analysts
152
Total ratings
29.82%
Success rate
-13.84%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLOV Clover Health Investments | Maintains: Buy | $3.7 → $3.2 | $1.86 | +72.04% | 7 | Mar 20, 2026 | |
| HCAT Health Catalyst | Maintains: Buy | $5 → $2 | $1.09 | +83.49% | 10 | Mar 13, 2026 | |
| PGNY Progyny | Maintains: Hold | $26 → $19 | $18.06 | +5.20% | 10 | Mar 11, 2026 | |
| TALK Talkspace | Downgrades: Hold | n/a | $5.14 | - | 3 | Mar 9, 2026 | |
| OMDA Omada Health | Maintains: Buy | $28 → $22 | $13.53 | +62.60% | 3 | Mar 6, 2026 | |
| PRVA Privia Health Group | Maintains: Buy | $34 → $35 | $21.03 | +66.43% | 10 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintains: Buy | $12 → $10 | $5.51 | +81.49% | 17 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $6.48 | +54.32% | 2 | Feb 26, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $54 → $30 | $24.06 | +24.69% | 7 | Feb 18, 2026 | |
| HNGE Hinge Health | Maintains: Buy | $65 → $53 | $41.28 | +28.41% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $34 | $24.43 | +39.17% | 14 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 | $20.68 | +35.43% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $33 | $11.26 | +193.07% | 12 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $9 | $2.25 | +300.00% | 13 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $1.6 → $1.5 | $0.64 | +133.21% | 8 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $11.48 | +30.66% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $127.41 | -5.03% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $28.52 | -15.85% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $67.64 | +40.46% | 9 | Apr 22, 2021 |
Clover Health Investments
Mar 20, 2026
Maintains: Buy
Price Target: $3.7 → $3.2
Current: $1.86
Upside: +72.04%
Health Catalyst
Mar 13, 2026
Maintains: Buy
Price Target: $5 → $2
Current: $1.09
Upside: +83.49%
Progyny
Mar 11, 2026
Maintains: Hold
Price Target: $26 → $19
Current: $18.06
Upside: +5.20%
Talkspace
Mar 9, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.14
Upside: -
Omada Health
Mar 6, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $13.53
Upside: +62.60%
Privia Health Group
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $35
Current: $21.03
Upside: +66.43%
Teladoc Health
Feb 26, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $5.51
Upside: +81.49%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $6.48
Upside: +54.32%
Waystar Holding
Feb 18, 2026
Maintains: Buy
Price Target: $54 → $30
Current: $24.06
Upside: +24.69%
Hinge Health
Feb 11, 2026
Maintains: Buy
Price Target: $65 → $53
Current: $41.28
Upside: +28.41%
Feb 9, 2026
Upgrades: Buy
Price Target: $48 → $34
Current: $24.43
Upside: +39.17%
Dec 17, 2025
Maintains: Hold
Price Target: $28
Current: $20.68
Upside: +35.43%
Dec 9, 2025
Maintains: Buy
Price Target: $38 → $33
Current: $11.26
Upside: +193.07%
Nov 14, 2025
Maintains: Buy
Price Target: $16 → $9
Current: $2.25
Upside: +300.00%
Nov 12, 2025
Maintains: Hold
Price Target: $1.6 → $1.5
Current: $0.64
Upside: +133.21%
Nov 6, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $11.48
Upside: +30.66%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $127.41
Upside: -5.03%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $28.52
Upside: -15.85%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $67.64
Upside: +40.46%